Billionaires Holding LPDX

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • -
    Shares Outstanding

  • 80.4M
    Market Cap

News & Insights

ABOUT

LPDX

LipoScience, Inc., a clinical diagnostic company, is engaged in the field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology in the United States. The company’s technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into...

Apple And Berkshire Hathaway: When Two Worlds Collide

NEWS

Icahn: Best Bet On Commodities

READ MORE